Treatment of disease or injury of the nervous system with fty720
CA 2539033 C · Owner: Lindquist, Per · Inventors: Lindquist, Per
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods for modulating , neurogenesis in vitro and in vivo have been disclosed. The methods comprise contacting neural stem cells with an effective amount of a FTY720 compound. The neurogenesis may involve the modulation of proliferation, differentiation, migration or survival of a non-embryonic neural stem cells or progenitor cells. Also disclosed are methods for the prevention or treatment of neurological disorders including Parkinson's desease, Parkinsonian disorders Hutington's disease, Alzheimer's disease amyotrophic lateral sclerosis, spinal ischemia ischemic stroke, spinal cord injury, cancer-related brain injury, and cancer-related spinal cord injury Shy-Drager syndrome, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 10, 2004 and granted March 5, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 10, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 10, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.